BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33217540)

  • 1. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.
    Heigl T; Saez-Gimenez B; Van Herck A; Kaes J; Sacreas A; Beeckmans H; Ambrocio GPL; Kwakkel-Van Erp H; Ordies S; Vanstapel A; Verleden SE; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verbeken E; Verleden GM; Vos R; Vanaudenaerde B
    Transpl Immunol; 2021 Feb; 64():101352. PubMed ID: 33217540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts.
    Girnita AL; Lee TM; McCurry KR; Baldwin WM; Yousem SA; Detrick B; Pilewski J; Toyoda Y; Jelinek L; Lomago J; Zaldonis D; Spichty KJ; Zeevi A
    Transplantation; 2008 Jul; 86(2):342-7. PubMed ID: 18645500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid.
    Miller GG; Destarac L; Zeevi A; Girnita A; McCurry K; Iacono A; Murray JJ; Crowe D; Johnson JE; Ninan M; Milstone AP
    Am J Transplant; 2004 Aug; 4(8):1323-30. PubMed ID: 15268735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
    Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
    Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute antibody-mediated rejection after lung transplantation.
    Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
    Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
    Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.
    Aguilar PR; Carpenter D; Ritter J; Yusen RD; Witt CA; Byers DE; Mohanakumar T; Kreisel D; Trulock EP; Hachem RR
    Am J Transplant; 2018 Apr; 18(4):936-944. PubMed ID: 28992372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies.
    Roden AC; Maleszewski JJ; Yi ES; Jenkins SM; Gandhi MJ; Scott JP; Aubry MC
    J Heart Lung Transplant; 2014 Dec; 33(12):1223-32. PubMed ID: 25149365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of C4d as a diagnostic adjunct in lung allograft biopsies.
    Magro CM; Pope Harman A; Klinger D; Orosz C; Adams P; Waldman J; Knight D; Kelsey M; Ross P
    Am J Transplant; 2003 Sep; 3(9):1143-54. PubMed ID: 12919095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
    Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
    Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.